Invention Grant
- Patent Title: Modulation of glucagon receptor expression
- Patent Title (中): 调节胰高血糖素受体表达
-
Application No.: US10832622Application Date: 2004-04-27
-
Publication No.: US07750142B2Publication Date: 2010-07-06
- Inventor: Susan M. Freier
- Applicant: Susan M. Freier
- Applicant Address: US CA Carlsbad
- Assignee: Isis Pharmaceuticals, Inc.
- Current Assignee: Isis Pharmaceuticals, Inc.
- Current Assignee Address: US CA Carlsbad
- Agency: McDermott Will & Emery LLP
- Main IPC: C07H21/04
- IPC: C07H21/04
Abstract:
Compounds, compositions and methods are provided for modulating the expression of glucagon receptor. The compositions comprise oligonucleotides, targeted to nucleic acid encoding glucagon receptor. Methods of using these compounds for modulation of glucagon receptor expression and for diagnosis and treatment of disease associated with expression of glucagon receptor are provided.
Public/Granted literature
- US20050014713A1 Modulation of glucagon receptor expression Public/Granted day:2005-01-20
Information query
